Presentations Availability
Presentations are being added—please check back.
Presentations from the 2025 Annual Meeting
- June Halper Memorial Lecture
Beyond the Diagnosis: A Legacy of Compassionate, Comprehensive and Innovative Care in Multiple Sclerosis
Marie Namey, APRN, MSCN
- John Kurtzke Memorial Lecture
Finding MS Therapies: Four Decades of Adventure and Misadventure
Robert J. Fox, MD, FAAN
- (CC01) Neuroanatomy for the MS Clinician: Insights and Clinical Pearls
- Introduction and Clinical Pearls
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN - The Brainstem and Cranial Nerves
Stephen Krieger, MD, FAAN - The Spinal Cord
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN - Summary and Q & A
- Introduction and Clinical Pearls
- (CC02) Updates in Management of Headache and Facial Pain: What the MS Clinician Needs to Know
- Introductions and Setting the Stage- Why MS Clinicians Need to Know about Headache
Anne Damian Yacoub, MD - Management of Trigeminal Neuralgia & Atypical Facial Pain
Tina Doshi, MD, MHS - Acute Treatment of Migraine
Amaal J. Starling, MD, FAHS, FAAN - Preventative Treatment of Migraine
Anne Damian Yacoub, MD - Wrap up and Q&A
- Introductions and Setting the Stage- Why MS Clinicians Need to Know about Headache
- (CC03) MOGAD in Focus: Diagnostic Criteria and Treatment Strategies
- MOGAD Diagnostic Criteria and Key Flags
Giulia Fadda, MD - Current and Emerging Therapies
Eoin P. Flanagan, MD - Unique Consideration in the Care of Pediatric MOGAD Patients
E. Ann Yeh, MD - Discussion and Q & A
Panel
- MOGAD Diagnostic Criteria and Key Flags
- (CC04) Brain Health and High Efficacy DMTs: A Combination Therapy for MS Clinical Practice
- Introduction and Overview / High Efficacy Treatment Landscape
Colleen Harris, MN, NP, MSCN, MSCS - Evidence on Brain Health in MS
Erin Wilkinson, MSN, APRN, FNP-BC, MSCN - Combining Treatment Strategies
Piet Eelen, RN, MSc - Case Studies
Panel
- Introduction and Overview / High Efficacy Treatment Landscape
- (CC05) Era of Too Many Choices; Starting and Switching
- Welcome and Introduction
Scott D. Newsome, DO, MSCS, FAAN, FANA - Treatment Approaches and Considerations in MS
Scott D. Newsome, DO, MSCS, FAAN, FANA - Decision Making Process Around What DMT to Start
Gabrielle Macaron, MD - Decision Making Process Around Switching DMTs in MS
Jiwon Oh, MD, PhD, FRCPC - Panel Roundtable-Case Presentations
Panel - Q&A
Panel
- Welcome and Introduction
- (CC06) Leveling Up: Enhancing the MS Clinical Assessment
- The Most Essential Test for MS You’re Not Doing: McArdle Sign
Brian G. Weinshenker, MD - “I Think My Memory is Fine!” … But is It Really? Cognitive Assessment in MS
Kathleen L. Fuchs, PhD - In the Shadow of Fatigue: Undiagnosed OSA in MS
Mini Singh, MD
- The Most Essential Test for MS You’re Not Doing: McArdle Sign
- (CC11) International Perspectives on the Importance of a Multidisciplinary Approach to Nutrition Care for MS
- Dietary Factors in MS Onset and Progression
Karen Zozsak, BMath (Comp Sci), BND, PhD Candidate, APD - Integrating Dietitians into the MS Care Team: Real-life Case Studies and Experience
Olivia Wills, PhD, APD - The Consumer Voice: Partnering with People Living with MS and Healthcare Professionals for Better MS Care
Shoroog Allogmanny, APD, PhD(C) - Where We are Headed: The Future with Shared Decision-making
Yasmine Probst, Prof, PhD, AdvAPD, FAIDH
- Dietary Factors in MS Onset and Progression
- (CC12) The Power of Prevention: A Focus on Immunology, Vaccine Recommendations and Infection Management
- Introduction
Jacquelyn Bainbridge, PharmD, FCCP, MSCS, FAES - Common Respiratory Infections
Diana Ung, PharmD, APh, CSP - COVID Management (Prophylaxis and Management)
Jacquelyn Bainbridge, PharmD, FCCP, MSCS, FAES - Vaccination Updates and Pearls
Michelle Maynard, PharmD, BCPS
- Introduction
- (SYM01) 2024 McDonald Diagnostic Criteria Revisions
- Introduction / History of Diagnostic Criteria and Methodology Used in the 2024 Update
Ruth Ann Marrie, MD, PhD, FRCPC, FCAHS - Optic Nerve as Fifth Topography
Other Changes to Dissemination in Space and Time
Peter Calabresi, MD - Fluid Biomarkers
Imaging Biomarkers in Diagnosing MS
RIS
Jiwon Oh, MD, PhD, FRCPC - Confirming a Diagnosis in Those over Age 50 and Those with Comorbidities
Ruth Ann Marrie, MD, PhD, FRCPC, FCAHS
- Introduction / History of Diagnostic Criteria and Methodology Used in the 2024 Update
- (SYM02) The Benefits of Day Programs as Part of Comprehensive Care for People Living with MS
- Introduction to MS Day Programs
Brian Hutchinson, PT, MSCS - History and Evolution of MS Day Programs
Randall T. Schapiro, MD, FAAN - Connection to Combat Loneliness and Isolation
Tiffany Malone, MSW, MSCS - Incorporating Lifestyle Neurology into MS Management
Barbara Giesser, MD, FAAN, FANA, Dipl. ABLM - Outcomes of MS Day Programs
Brian Hutchinson, PT, MSCS
- Introduction to MS Day Programs
- (SYM06) Menopause as a Modifiable Risk Factor
- (SYM07) Pediatric Demyelinating Disease: Critical Aspects of Care, Treatment and Transition
- Introduction
Yolanda Wheeler, PhD, CRNP, CPNP-AC, MSCN - Why an Adult MS Physician Needs to Know about Pediatric MS (and Other Demyelinating Diseases)
Aaron W. Abrams, MD - Mimics of Pediatric MS
Kelsey Poisson, MD - Treatments of Pediatric MS and Related Conditions
Nikita Malani Shukla, MD - Transition of Care
Yolanda Wheeler, PhD, CRNP, CPNP-AC, MSCN
- Introduction
- (SYM08) Whitaker Track Invited Lectures: MS in Special Populations
- Advanced Disease States in Multiple Sclerosis: A Clinical Perspective
Sam Hooshmand. DO - Aging and MS: From Geriatrics to Gerotherapeutics
Yinan Zhang, MD, MS - Pediatric MS: Opportunities and Unmet Needs
Grace Gombolay, MD, MSc
- Advanced Disease States in Multiple Sclerosis: A Clinical Perspective
- (SYM11) Developing Effective Models of Care for People Living with Advanced MS
- Introduction
Rachael Stacom, ANP-BC, MSN, MSCN - Developing a Care Management Model: Using Data to Improve Systems of Care and Improve Health Outcomes
Rachael Stacom, ANP-BC, MSN, MSCN - Approach to Symptom Management in Advanced MS
Stephen Krieger, MD - Using Adaptive Equipment and Assistive Technology to Maximize Function in Advanced MS
Elaine Castelluccio, PT, MPT, MSCS, CDP - A Home-based Model of Care Serving Individuals Living with MS and Significant Disability
Renee Stewart, APRN-NP, DNP
- Introduction
- (SYM12) Optimizing DMT Management in Multiple Sclerosis: Addressing Challenges and Enhancing Patient Care
Organized by the VA MS Centers of Excellence- DMTs in the MS Spectrum: Navigating Phenotypes, Aging, and Perioperative Challenges
John R. Rinker, II, MD - Understanding Infection Risks in MS: Identifying High-Risk Patients on DMTs
Anza Memon, MD, FAAN - Vaccination in MS: Strategies for Maximizing Efficacy and Safety
Suma Shah, MD - Intervention Implementation: Where the Rubber Meets the Road
Heidi Maloni, PhD, CNRN
- DMTs in the MS Spectrum: Navigating Phenotypes, Aging, and Perioperative Challenges
- (SYM14) Unlocking Relief: MS Symptom Management Strategies
- Counting Desert Flowers: A Review of DMTs and the Progression to Controlled MS
Amanda Hickman, PharmD, MPH, MSCS - Waking up, Shutting Down, and all the Confusion in between: A Discussion on Fatigue, Sleep and Cognitive Fatigue Management
Nancy Ross, PharmD, BCACP, MSCS, CSP - Mind over MS: Navigating the Management of Multiple Sclerosis and Mood Disorders
Jenelle H. Montgomery, PharmD, BCACP, CPP - Management of Pain, Spasticity, and Restless Legs
Nicole Yvonne Nguyen, PharmD, BCPS
- Counting Desert Flowers: A Review of DMTs and the Progression to Controlled MS
- (SYM17) Cases in Neuromyelitis Optica Spectrum Disorder and MOG Antibody-Associated Disease
- Introduction and Cases in MOGAD Diagnosis
Eoin P. Flanagan, MD, MBBCh - Cases in NMOSD Diagnosis
Brian G. Weinshenker, MD - Cases in MOGAD Treatment
Smathorn Thakolwiboon, MD - Cases in NMOSD Treatment
Shailee Shah, MD
- Introduction and Cases in MOGAD Diagnosis
- (SYM19) Multiple Sclerosis and Fatigue: An Update and Overview of Clinical Trials and Management
Organized by the VA MS Centers of Excellence- Introduction / Pharmacology: Overview and Update
Mitchell Wallin, MD, MPH - Behavioral Intervention: Overview and Update
Aaron Turner, PhD - What Does the Brain Tell Us About Interventions for Fatigue?
John DeLuca, PhD, ABPP - Intervention Implementation: Where the Rubber Meets the Road
Lindsey Knowles, PhD
- Introduction / Pharmacology: Overview and Update
- (SYM20) MS Update 2025-What Everyone Wants to Know in 2025: Exploring the Latest Topics in MS
- Accurate Family Planning/Counseling for MS and NMOSD
Patricia K. Coyle MD, FAAN, FANA - Current MS Diagnostic Issues
Patricia K. Coyle MD, FAAN, FANA - Data on When to Discontinue Therapy
Marijean Buhse, PhD, RN, ANP-BC, MSCN, FAAN - MOGAD Pearls
Patricia Melville, RN, MSN, NP-BC, MSCN - Symptom Management-Focus on Gait and Bladder
Marijean Buhse, PhD, RN, ANP-BC, MSCN, FAAN - Late Anti-CD 20 Issues (Hypogammaglobulinemia, Neutropenia, Immune Colitis)
Patricia Melville, RN, MSN, NP-BC, MSCN - Deciphering PIRA
Patricia K. Coyle MD, FAAN, FANA
- Accurate Family Planning/Counseling for MS and NMOSD
- (SYM21) Increasing Diversity in Clinical Research: Practical Applications
- Introduction: Multistakeholder Solutions
Mitzi Joi Williams, MD, FAAN, - The Investigator Role
Annette F. Okai, MD, FAAN - Role of Research Staff
Jacqueline Rosenthal, MD - Building Community Partnerships
Annette Howard, MD - Role of Academic Institutions/Learning Environments
Mima Akinsanya, MD
- Introduction: Multistakeholder Solutions
- (SYM23) MS in Underserved Populations: Understanding Needs and Improving Outcomes
- Introduction and SDOH and Health Outcomes
Mitzi Joi Williams, MD, FAAN - MS in Ethnic Minority Populations
Jakai Nolan McEwen, DO, MPH - Patient Perspective on Care Gaps
Victoria Reese - MS in LGBTQIA Populations
William Conte, MD - MS Across the Ages Under 18 and Over 55
Jennifer Graves, MD
- Introduction and SDOH and Health Outcomes
- (SYM24) Treatment Strategies in Relapsing MS
- Introduction
Scott D. Newsome, DO, MSCS, FAAN, FANA - Birds Eye View on Treatment Strategies
Scott D. Newsome, DO, MSCS, FAAN, FANA - Treatment Strategies in Multiple Sclerosis are Clear as a
Crystal Tirisham Gyang, MD - Treatment Strategies in Multiples Sclerosis are Clear as Mud
Ellen Mowry, MD, MCR, FAAN, FANA - Panel Roundtable-Case Presentations
- Introduction
- Disease Modifying Therapies Platforms
- No Rebound Observed Following Ozanimod Discontinuation in Female and Male Participants in the DAYBREAK Open-Label Extension Study
Bruce A.C. Cree, MD, PhD, MAS - Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and Potential Impact on B-Cell Levels: The Minore and Sopranino Trials
Riley Bove, MD - A Phase 1 Dose-Escalation Study of BMS-986353, a CD19 NEX-T, Evaluating Safety and Tolerability in Relapsing or Progressive Forms of Multiple Sclerosis (MS): Breakfree-2
Claire S. Riley, MD - Disability Outcomes in Tolebrutinib Phase 3 Trials in Non-Relapsing Secondary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis
Jiwon Oh, MD, PhD, FRCPC - Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the Fenopta Open-Label Extension
Amit Bar-Or, MD - Safety and Efficacy of Frexalimab from the Phase 2 Open-Label Extension in Participants with Relapsing Multiple Sclerosis: 2-Year Results
Stephen Krieger, MD
- No Rebound Observed Following Ozanimod Discontinuation in Female and Male Participants in the DAYBREAK Open-Label Extension Study
- Disease Management Platforms
- Impact of Relapses on Quality of Life and Economic Disease Burden in US Patients with Neuromyelitis Optica Spectrum Disorder
Benjamin J. Osborne, MD - The MS-Link™ Outcomes Study: Study Design and Descriptive Analyses of Patient-Reported Outcomes, Disease, and Sociodemographic Characteristics
Jeffrey English, MD - Reduce Your Risk of Falls©: A Group Coaching Program to Increase Mobility Confidence and Reduce Fall Risk in People with MS
Laura Allen, Associate Vice President of Operations - Disparities of Hypertension Awareness in Multiple Sclerosis: Age, Sex, and Severity
Michael V. Robers, MD, MS - Wearable Devices for Monitoring Incomplete Bladder Emptying in Multiple Sclerosis
Riley Bove, MD - No Association between Decreases in Serum Immunoglobulin Levels and Serious Infections with Long-Term Ublituximab Treatment in Patients with Relapsing Multiple Sclerosis
Bruce A.C. Cree, MD, PhD, MAS
- Impact of Relapses on Quality of Life and Economic Disease Burden in US Patients with Neuromyelitis Optica Spectrum Disorder
- Fundamentals of MS Care Part 1
- The Natural History of MS (Epidemiology, Immunology, Pathophysiology)
Bruce Cohen, MD - Making the Diagnosis (Disease Mimics, Use of Paraclinical Tools)
Derrick Robertson, MD - MRI Mimics in the Diagnosis of MS
David Li, MD - Primary Progressive MS: Diagnosis, Clinical Course, and Management
Patricia Coyle, MD
- The Natural History of MS (Epidemiology, Immunology, Pathophysiology)
- Fundamentals of MS Care Part 2
- Use and Effectiveness of Marijuana in MS: Research Update
Anthony Feinstein, MD, PhD, FRCPC - Women’s Issues in MS: Pregnancy, Sexual Function and Menopause
Riley Bove, MD - Day to Day Management: The Role of Triage Nurse
Charlotte Craig, MSN, RN, MSCN - Research in MS: Recruiting into Trials and the Role of the Research Nurse
Christina Isabell, RN
- Use and Effectiveness of Marijuana in MS: Research Update
- Fundamentals of MS Care Part 3
Initial Treatment Options, Clinical Support for the Newly Diagnosed, Aging and Disabled Populations and Nutrition Pearls- Welcome and Overview
Beverly Layton, RN, BSN, MSCN - Initial Choice of Disease Modifying Therapy in RRMS
John R. Rinker, II, MD - The Role of Nurse Practitioners in the Care of the Newly Diagnosed MS Patient
Wallette G. Widener, PhD, APRN, FNP, MSCN, CNRN - Aging and Disability in MS
Crystal Wright, RN, MSN, AGPCNP-BC, MSCN - Ask the Dietitian-How to Navigate Frequently Asked Questions on Diet and MS
Mona Bostick, RDN, LDN, MSCS
- Welcome and Overview
- Fundamentals of MS Care – Part 4: Common Symptoms in MS: Visible, Invisible and Clinical Pearls of Management by a Care Team
- Welcome and Overview
Beverly Layton, RN, BSN, MSCN - Introduction and MS Symptoms Above the Waist
Sara Schaefer, NP-BC, CNRN, MSCN - MS Symptoms Below the Waist
Jeffrey Hernandez, DNP, APRN, MSCN - Clinical Pearls of Management by a Care Team
Tomicka McMillion, DNP, RN, MSCN
- Welcome and Overview
- Current Topics and Trends in MS Rehab
Part 2 – Evidence-based Approaches to Physical Rehabilitation Across the MS Disease Course: A Focus on Clinical Application- Overview of Evidence-based Approaches to Mobility Training Across the MS Disease Course
Sarah Donkers, BSc, MPT, MSc, PhD - Team-based Approach and Decision Making in Spasticity Management
Rajiv Reebye. MD - Small Group Guided Learning Activity
Panel - Adaptive and Assistive Devices for Mobility Across the MS Disease Course
Katherine Knox, MD - Lab Based Activity for Specialized Seating
Amy Spiers, BScOT
- Overview of Evidence-based Approaches to Mobility Training Across the MS Disease Course
- June Halper Memorial Lecture
- John Whitaker Lecture
Pregnancy, Lactation and Menopause
Riley M. Bove, MD - (CC01) Neuroanatomy for the MS Clinician: Insights and Clinical Pearls
- Introduction and Clinical Pearls
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN - The Brainstem and Cranial Nerves
Stephen Krieger, MD, FAAN - The Spinal Cord
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN - Summary and Q & A
- Introduction and Clinical Pearls
- (CC03) MOGAD in Focus: Diagnostic Criteria and Treatment Strategies
- MOGAD Diagnostic Criteria and Key Flags
Giulia Fadda, MD - Current and Emerging Therapies
Eoin P. Flanagan, MD - Unique Consideration in the Care of Pediatric MOGAD Patients
E. Ann Yeh, MD - Discussion and Q & A
Panel
- MOGAD Diagnostic Criteria and Key Flags
- (SYM01) 2024 McDonald Diagnostic Criteria Revisions
- Introduction / History of Diagnostic Criteria and Methodology Used in the 2024 Update
Ruth Ann Marrie, MD, PhD, FRCPC, FCAHS - Optic Nerve as Fifth Topography
Other Changes to Dissemination in Space and Time
Peter Calabresi, MD - Fluid Biomarkers
Imaging Biomarkers in Diagnosing MS
RIS
Jiwon Oh, MD, PhD, FRCPC - Confirming a Diagnosis in Those over Age 50 and Those with Comorbidities
Ruth Ann Marrie, MD, PhD, FRCPC, FCAHS
- Introduction / History of Diagnostic Criteria and Methodology Used in the 2024 Update
- (SYM03) Basic and Advanced Immunology for the Non-Immunologist
- Welcome and Introduction
Scott D. Newsome, DO, MSCS, FAAN, FANA - How Does the Immune System Protect Us?
Lisa Fox, PA-C, MPAS - The Immune System Goes Rogue in Multiple Sclerosis
Jennifer Orthmann-Murphy, MD, PhD - Genetics in MS and the Role of Immune Cell Genetics in MS
Philip De Jager, MD, PhD
- Welcome and Introduction
- (SYM04) Promoting Remyelination in MS
- Introduction and Biology of Remyelination
V. Wee Yong, PhD, FCAHS, FRSC - Remyelination in MS
Tanja Kuhlmann, MD - Translational Medicine for Remyelination
Peter Calabresi, MD - Emerging Serum and Imaging Biomarkers to Monitor Remyelination in MS
Ahmed Abdelhak, MD
- Introduction and Biology of Remyelination
- (SYM08) Whitaker Track Invited Lectures: MS in Special Populations
- Advanced Disease States in Multiple Sclerosis: A Clinical Perspective
Sam Hooshmand. DO - Aging and MS: From Geriatrics to Gerotherapeutics
Yinan Zhang, MD, MS - Pediatric MS: Opportunities and Unmet Needs
Grace Gombolay, MD, MSc
- Advanced Disease States in Multiple Sclerosis: A Clinical Perspective
- (SYM09) The Evolving Field of Fluid Biomarkers for Managing MS
- Introduction
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC - Neurofilament Light Chain (NfL): Informative Across the Spectrum of MS for Prognosis, Disease Monitoring and Treatment Response
Enric Monreal, MD, PhD - Glial Fibrillary Acidic Protein: Evolving Understanding for Both Relapsing and Progressive Forms of MS
Simon Thebault, MBBCh, MSc, PhD, MRCP(UK), FRCPC - Practical Application of Biomarkers in the day-to-day Management of MS
Tanuja Chitnis, MD - Clinical Cases for Discussion
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
- Introduction
- (SYM10) Genetic Predictors of MS Risk and Prognosis: Research Updates and a Path Forward
- Genetic Contributions to MS Risk in Diverse Populations
Ashley H. Beecham, PhD - Genetic Contributors to MS Severity
Adil Harroud, MD - Using Polygenic Risk Scores to Understand the Impact of Comorbidity on Outcomes in People with MS
Kaarina Kowalec, PhD
- Genetic Contributions to MS Risk in Diverse Populations
- (SYM15) Whitaker Platform Session
- Social Drivers of Health Exacerbate Multiple Sclerosis Disability Accrual and Mobility Impairment While on Anti-CD20 Treatment
Alexandra Balshi, BS - Exploring the Brain Networks Underlying Concern about Falling in MS: Amygdala, Hippocampal, and Cerebellar Connectivity
Taylor Takla, BS - Oral Microbiome Alterations in Multiple Sclerosis Characterized By Long Amplicon Sequencing
Jordan Shaked, BA - Movement-Evoked Pain Influences Neuromuscular Fatigue in People with Multiple Sclerosis
Mitra Rouhani, PhD, BSPT - Real World Efficacy of Cladribine Tablets in a Canadian Tertiary Centre Beyond 4 Years after Initiation
Katherine Sawicka, MD - B-Cell Repopulation and Biomarker Pathways in Multiple Sclerosis: Insights from Ofatumumab Therapy
Sara Esmaeili, MD, MPH, PhD
- Social Drivers of Health Exacerbate Multiple Sclerosis Disability Accrual and Mobility Impairment While on Anti-CD20 Treatment
- SYM16 Novel Imaging Biomarkers in the New Diagnostic Criteria of MS
- New Diagnostic Criteria for MS
Daniel Ontaneda, MD, PhD - When and How to Image Patients with MS
Nancy Sicotte, MD - New Biomarkers: CVS and PRL
Daniel Ontaneda, MD, PhD - Imaging CVS and PRL
Pascal Sati, PhD - Clinical Cases for Discussion Panel
Nancy Sicotte, MD
- New Diagnostic Criteria for MS
- (SYM17) Cases in Neuromyelitis Optica Spectrum Disorder and MOG Antibody-Associated Disease
- Introduction and Cases in MOGAD Diagnosis
Eoin P. Flanagan, MD, MBBCh - Cases in NMOSD Diagnosis
Brian G. Weinshenker, MD - Cases in MOGAD Treatment
Smathorn Thakolwiboon, MD - Cases in NMOSD Treatment
Shailee Shah, MD
- Introduction and Cases in MOGAD Diagnosis
- Disease Modifying Therapies Platforms
- No Rebound Observed Following Ozanimod Discontinuation in Female and Male Participants in the DAYBREAK Open-Label Extension Study
Bruce A.C. Cree, MD, PhD, MAS - Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and Potential Impact on B-Cell Levels: The Minore and Sopranino Trials
Riley Bove, MD - A Phase 1 Dose-Escalation Study of BMS-986353, a CD19 NEX-T, Evaluating Safety and Tolerability in Relapsing or Progressive Forms of Multiple Sclerosis (MS): Breakfree-2
Claire S. Riley, MD - Disability Outcomes in Tolebrutinib Phase 3 Trials in Non-Relapsing Secondary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis
Jiwon Oh, MD, PhD, FRCPC - Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the Fenopta Open-Label Extension
Amit Bar-Or, MD - Safety and Efficacy of Frexalimab from the Phase 2 Open-Label Extension in Participants with Relapsing Multiple Sclerosis: 2-Year Results
Stephen Krieger, MD
- No Rebound Observed Following Ozanimod Discontinuation in Female and Male Participants in the DAYBREAK Open-Label Extension Study
- Disease Management Platforms
- Impact of Relapses on Quality of Life and Economic Disease Burden in US Patients with Neuromyelitis Optica Spectrum Disorder
Benjamin J. Osborne, MD - The MS-Link™ Outcomes Study: Study Design and Descriptive Analyses of Patient-Reported Outcomes, Disease, and Sociodemographic Characteristics
Jeffrey English, MD - Reduce Your Risk of Falls©: A Group Coaching Program to Increase Mobility Confidence and Reduce Fall Risk in People with MS
Laura Allen, Associate Vice President of Operations - Disparities of Hypertension Awareness in Multiple Sclerosis: Age, Sex, and Severity
Michael V. Robers, MD, MS - Wearable Devices for Monitoring Incomplete Bladder Emptying in Multiple Sclerosis
Riley Bove, MD - No Association between Decreases in Serum Immunoglobulin Levels and Serious Infections with Long-Term Ublituximab Treatment in Patients with Relapsing Multiple Sclerosis
Bruce A.C. Cree, MD, PhD, MAS
- Impact of Relapses on Quality of Life and Economic Disease Burden in US Patients with Neuromyelitis Optica Spectrum Disorder
- Epidemiology and Social Determinants of Health
- Disease Severity and Disparities in Black and White People with Multiple Sclerosis: Sociodemographic and Modifiable Lifestyle Factors in a New York Population
Sarah Levy, PhD - Characterizing Disability and MRI Outcomes in Latinx People with Multiple Sclerosis before and after the COVID-19 Pandemic
Carrie M. Hersh, DO, MSc, FAAN - Optical Coherence Tomography Hyper-Reflective Foci in Pediatric Onset Multiple Sclerosis
Curtis M. Hay, MD, PhD - Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple Sclerosis
Fatemeh Siavoshi, MD - Race-Based Identity and Its Relationship with Neighborhood Marginalization and Mental Health in Pediatric-Onset Multiple Sclerosis
Paul Y. Yoo, PhD, OT - Clinical and Radiological Features in Mog-Negative Vs Mog-Positive Pediatric Acute Demyelinating Syndromes: One Entity or Multiple?
Areej Mahjoub, MD, FRCPC
- Disease Severity and Disparities in Black and White People with Multiple Sclerosis: Sociodemographic and Modifiable Lifestyle Factors in a New York Population
- (CC02) Updates in Management of Headache and Facial Pain: What the MS Clinician Needs to Know
- Introductions and Setting the Stage- Why MS Clinicians Need to Know about Headache
Anne Damian Yacoub, MD - Management of Trigeminal Neuralgia & Atypical Facial Pain
Tina Doshi, MD, MHS - Acute Treatment of Migraine
Amaal J. Starling, MD, FAHS, FAAN - Preventative Treatment of Migraine
Anne Damian Yacoub, MD - Wrap up and Q&A
- Introductions and Setting the Stage- Why MS Clinicians Need to Know about Headache
- (CC12) The Power of Prevention: A Focus on Immunology, Vaccine Recommendations and Infection Management
- Introduction
Jacquelyn Bainbridge, PharmD, FCCP, MSCS, FAES - Common Respiratory Infections
Diana Ung, PharmD, APh, CSP - COVID Management (Prophylaxis and Management)
Jacquelyn Bainbridge, PharmD, FCCP, MSCS, FAES - Vaccination Updates and Pearls
Michelle Maynard, PharmD, BCPS
- Introduction
- (SYM14) Unlocking Relief: MS Symptom Management Strategies
- Counting Desert Flowers: A Review of DMTs and the Progression to Controlled MS
Amanda Hickman, PharmD, MPH, MSCS - Waking up, Shutting Down, and all the Confusion in between: A Discussion on Fatigue, Sleep and Cognitive Fatigue Management
Nancy Ross, PharmD, BCACP, MSCS, CSP - Mind over MS: Navigating the Management of Multiple Sclerosis and Mood Disorders
Jenelle H. Montgomery, PharmD, BCACP, CPP - Management of Pain, Spasticity, and Restless Legs
Nicole Yvonne Nguyen, PharmD, BCPS
- Counting Desert Flowers: A Review of DMTs and the Progression to Controlled MS
- (SYM20) MS Update 2025-What Everyone Wants to Know in 2025: Exploring the Latest Topics in MS
- Accurate Family Planning/Counseling for MS and NMOSD
Patricia K. Coyle MD, FAAN, FANA - Current MS Diagnostic Issues
Patricia K. Coyle MD, FAAN, FANA - Data on When to Discontinue Therapy
Marijean Buhse, PhD, RN, ANP-BC, MSCN, FAAN - MOGAD Pearls
Patricia Melville, RN, MSN, NP-BC, MSCN - Symptom Management-Focus on Gait and Bladder
Marijean Buhse, PhD, RN, ANP-BC, MSCN, FAAN - Late Anti-CD 20 Issues (Hypogammaglobulinemia, Neutropenia, Immune Colitis)
Patricia Melville, RN, MSN, NP-BC, MSCN - Deciphering PIRA
Patricia K. Coyle MD, FAAN, FANA
- Accurate Family Planning/Counseling for MS and NMOSD
- Fundamentals of MS Care – Part 4: Common Symptoms in MS: Visible, Invisible and Clinical Pearls of Management by a Care Team
- Welcome and Overview
Beverly Layton, RN, BSN, MSCN - Introduction and MS Symptoms Above the Waist
Sara Schaefer, NP-BC, CNRN, MSCN - MS Symptoms Below the Waist
Jeffrey Hernandez, DNP, APRN, MSCN - Clinical Pearls of Management by a Care Team
Tomicka McMillion, DNP, RN, MSCN
- Welcome and Overview
- Donald Paty Lecture
Is It Time to Consider MS Depression a Unique Diagnosis?
Anthony Feinstein, MD, PhD, FRCPC - (CC06) Leveling Up: Enhancing the MS Clinical Assessment
- The Most Essential Test for MS You’re Not Doing: McArdle Sign
Brian G. Weinshenker, MD - “I Think My Memory is Fine!” … But is It Really? Cognitive Assessment in MS
Kathleen L. Fuchs, PhD - In the Shadow of Fatigue: Undiagnosed OSA in MS
Mini Singh, MD
- The Most Essential Test for MS You’re Not Doing: McArdle Sign
- (CC08) Assessment and Treatment of Sexual Dysfunction
Frederick W. Foley, PhD - (CC09) Identifying and Monitoring Cognitive Impairment: An IMSCOGS Session
- Introduction
Menno Schoonheim, PhD - The Importance of Early Identification of Cognitive Impairment
Sarah A. Morrow, MD, MS, FRCPC - Advancing Our Understanding of Cognitive Biomarkers – MRI
Menno Schoonheim, PhD - Introduction of New, Expert Reviewed International Guidelines
Laura Hancock, PhD
- Introduction
- (SYM02) The Benefits of Day Programs as Part of Comprehensive Care for People Living with MS
- Introduction to MS Day Programs
Brian Hutchinson, PT, MSCS - History and Evolution of MS Day Programs
Randall T. Schapiro, MD, FAAN - Connection to Combat Loneliness and Isolation
Tiffany Malone, MSW, MSCS - Incorporating Lifestyle Neurology into MS Management
Barbara Giesser, MD, FAAN, FANA, Dipl. ABLM - Outcomes of MS Day Programs
Brian Hutchinson, PT, MSCS
- Introduction to MS Day Programs
- (SYM05) Patient-Centered Cognitive Wellness Approaches for People with Multiple Sclerosis
Terry Lee-Wilk, PhD; Moira Dux, PhD; Jessica Dalrymple, PhD - (SYM13) What Does the Brain Tell Us About Fatigue? Clinical Implications
- Introduction / Why is Fatigue so Poorly Understood-History and Measurement
John DeLuca, PhD, ABPP - How is Fatigue Represented in the Brain? Neural Mechanisms
Glenn Wylie, PhD - Neuroimaging and Depression-What Does This Tell Us About Fatigue?
Anthony Feinstein, MD, PhD
- Introduction / Why is Fatigue so Poorly Understood-History and Measurement
- (SYM14) Unlocking Relief: MS Symptom Management Strategies
- Counting Desert Flowers: A Review of DMTs and the Progression to Controlled MS
Amanda Hickman, PharmD, MPH, MSCS - Waking up, Shutting Down, and all the Confusion in between: A Discussion on Fatigue, Sleep and Cognitive Fatigue Management
Nancy Ross, PharmD, BCACP, MSCS, CSP - Mind over MS: Navigating the Management of Multiple Sclerosis and Mood Disorders
Jenelle H. Montgomery, PharmD, BCACP, CPP - Management of Pain, Spasticity, and Restless Legs
Nicole Yvonne Nguyen, PharmD, BCPS
- Counting Desert Flowers: A Review of DMTs and the Progression to Controlled MS
- (SYM19) Multiple Sclerosis and Fatigue: An Update and Overview of Clinical Trials and Management
Organized by the VA MS Centers of Excellence- Introduction / Pharmacology: Overview and Update
Mitchell Wallin, MD, MPH - Behavioral Intervention: Overview and Update
Aaron Turner, PhD - What Does the Brain Tell Us About Interventions for Fatigue?
John DeLuca, PhD, ABPP - Intervention Implementation: Where the Rubber Meets the Road
Lindsey Knowles, PhD
- Introduction / Pharmacology: Overview and Update
- (SYM22) When Fulfillment Becomes an Internal Fight: Managing Burnout in Medicine
- Introductions and Worldview
Amy Sullivan, PsyD, ABPP - Impact of Stress on the Body
Amy Sullivan, PsyD, ABPP - Burnout Stories with Audience Process
Amy Sullivan, PsyD, ABPP; Carrie M. Hersh, DO, MSc, FAAN - Combating Burnout & Time Management for Work-Life Integration
Carrie M. Hersh, DO, MSc, FAAN
- Introductions and Worldview
- Imaging, Cognitive, and Psychosocial Features of MS and Related Disorders
- Towards Precision Medicine in MS: Subjective Cognitive Fatigability Is Related to Psychosocial Fatigue, Cognitive Impairment, and Disability
Candice L. Craft, MS - Sulcal Morphometry Is Associated with Cognitive Performance and Cognitive Fatigue in Multiple Sclerosis
Cristina A.F. Román, PhD - Cognitive Concerns and Work: A Collaborative Occupational Therapy and Speech and Language Pathology Approach to Assessment and Treatment
Megan Parker, MScOT - Management of Psychological Comorbidities in Neuroimmunologic Disease
Virginia Baker, MD - The Importance of Super-Resolution and Harmonization in a Pragmatic Clinical MR Image Dataset
Savannah P. Hays, MSE - Remote Cognitive Monitoring in MS: A Path Toward Holistic Care with the Icometrix Platform
Enrique Alvarez, MD, PhD
- Towards Precision Medicine in MS: Subjective Cognitive Fatigability Is Related to Psychosocial Fatigue, Cognitive Impairment, and Disability
- Epidemiology and Social Determinants of Health
- Disease Severity and Disparities in Black and White People with Multiple Sclerosis: Sociodemographic and Modifiable Lifestyle Factors in a New York Population
Sarah Levy, PhD - Characterizing Disability and MRI Outcomes in Latinx People with Multiple Sclerosis before and after the COVID-19 Pandemic
Carrie M. Hersh, DO, MSc, FAAN - Optical Coherence Tomography Hyper-Reflective Foci in Pediatric Onset Multiple Sclerosis
Curtis M. Hay, MD, PhD - Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple Sclerosis
Fatemeh Siavoshi, MD - Race-Based Identity and Its Relationship with Neighborhood Marginalization and Mental Health in Pediatric-Onset Multiple Sclerosis
Paul Y. Yoo, PhD, OT - Clinical and Radiological Features in Mog-Negative Vs Mog-Positive Pediatric Acute Demyelinating Syndromes: One Entity or Multiple?
Areej Mahjoub, MD, FRCPC
- Disease Severity and Disparities in Black and White People with Multiple Sclerosis: Sociodemographic and Modifiable Lifestyle Factors in a New York Population
- Donald Paty Lecture
- (CC07) The Interdisciplinary Approach to Wellness in MS
- The Interdisciplinary Approach to Wellness in MS
Mary Rensel, MD, FAAN; Alyssa DeCarlo, MS, OTR/L, MSCS - The Concept of MS Interdisciplinary Care “looping” It Takes a Village
Mary Mazzola, MA, CCC-SLP; Hannah Malloy, PT, DPT, NCS - Wellness in MS, Interdisciplinary Case Discussions
Panel
- The Interdisciplinary Approach to Wellness in MS
- Current Topics and Trends in MS Rehab
Part 1 – Maximizing Brain Health in Multiple Sclerosis- Defining Brain Health in MS
Bianca Weinstock-Guttman, MD - Evidence for Rehabilitation Effects on Brain Health in MS
Brian M. Sandroff, PhD - Promoting Brain Health Enhancing Approaches in Comprehensive MS Care
Robert W. Motl, PhD - Maximizing Brain Health in MS: Insights from Real-World Clinical Experience
Augusto Miravalle, MD
- Defining Brain Health in MS
- Current Topics and Trends in MS Rehab
Part 2 – Evidence-based Approaches to Physical Rehabilitation Across the MS Disease Course: A Focus on Clinical Application- Overview of Evidence-based Approaches to Mobility Training Across the MS Disease Course
Sarah Donkers, BSc, MPT, MSc, PhD - Team-based Approach and Decision Making in Spasticity Management
Rajiv Reebye. MD - Small Group Guided Learning Activity
Panel - Adaptive and Assistive Devices for Mobility Across the MS Disease Course
Katherine Knox, MD - Lab Based Activity for Specialized Seating
Amy Spiers, BScOT
- Overview of Evidence-based Approaches to Mobility Training Across the MS Disease Course
- Current Topics and Trends in MS Rehab
Part 3 – Network Failure and Behavioral Interventions in Multiple Sclerosis- The Network Collapse as a Framework for Understanding Clinical Progression in MS
Menno M. Schoonheim, PhD - Diet as an Approach for Mitigating Network Collapse in MS
Ilana Katz-Sand, MD - Exercise as an Approach for Mitigating Network Collapse in MS
Brian M. Sandroff, PhD - Harnessing Transcranial Direct Current Stimulation for Functional Recovery and Preservation in MS
Leigh Charvet, PhD - Discussion: The Path Forward – Preparing for Integration in Future RCTs
Robert W. Motl, PhD and Panel
- The Network Collapse as a Framework for Understanding Clinical Progression in MS
- Current Topics and Trends in MS Rehab – Part 4
- Session A: Vision Dysfunction and Retraining in Multiple Sclerosis
- Introduction / Optic Neuritis/Optimizing Low Vision
Clotilde M. Hainline, MD - Efferent Dysfunction in MS/Corrective Strategies for Efferent Dysfunction
Scott N. Grossman, MD
- Introduction / Optic Neuritis/Optimizing Low Vision
- Session A: Vision Dysfunction and Retraining in Multiple Sclerosis
- Rehabilitation Platforms
- Is There a Threshold or Dose-Response Association between Physical Activity and Cognitive Function in Multiple Sclerosis?
Brenda Jeng, PhD - Long-Term Efficacy of Translingual Neurostimulation By a Portable Neuromodulation Stimulator on Gait Deficit Improvement in Multiple Sclerosis: Results from Ponstep Study
Deborah Backus, PhD, PT - Effectiveness of Facility-Based and Home-Based Exercise Programs for Multiple Sclerosis: The STEP for MS Trial
Deborah Backus, PhD, PT - Balancing Fatigue Mechanisms in Multiple Sclerosis through Low Load Blood Flow Restriction Resistance Exercise
Ethan C. Hill, PhD - Psychometric Properties of Free-Living Step-Based Metrics (Daily Steps and Peak Cadence) in Multiple Sclerosis
Peixuan Zheng, PhD - Walk It out: Acute Treadmill Walking Exercise Reduces State Anxiety in People with Multiple Sclerosis Who Have Generalized Anxiety Disorder
Petra Šili, BS
- Is There a Threshold or Dose-Response Association between Physical Activity and Cognitive Function in Multiple Sclerosis?
- (CC07) The Interdisciplinary Approach to Wellness in MS
- The Interdisciplinary Approach to Wellness in MS
Mary Rensel, MD, FAAN; Alyssa DeCarlo, MS, OTR/L, MSCS - The Concept of MS Interdisciplinary Care “looping” It Takes a Village
Mary Mazzola, MA, CCC-SLP; Hannah Malloy, PT, DPT, NCS - Wellness in MS, Interdisciplinary Case Discussions
Panel
- The Interdisciplinary Approach to Wellness in MS
- (CC10) Wellness in MS: Mindfulness & Coaching
- Wellness
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN - Mindfulness in MS
Libby Levine, MSN, APRN, AGNP-BC, MSCN - Coaching in MS
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN - Complementary Therapies
Sarah Cecil, DNP, APRN, FNP-BC, PMHNP-BC, MSCN - Case Studies & Summary
Libby Levine, MSN, APRN, AGNP-BC, MSCN
- Wellness
- (CC11) International Perspectives on the Importance of a Multidisciplinary Approach to Nutrition Care for MS
- Dietary Factors in MS Onset and Progression
Karen Zozsak, BMath (Comp Sci), BND, PhD Candidate, APD - Integrating Dietitians into the MS Care Team: Real-life Case Studies and Experience
Olivia Wills, PhD, APD - The Consumer Voice: Partnering with People Living with MS and Healthcare Professionals for Better MS Care
Shoroog Allogmanny, APD, PhD(C) - Where We are Headed: The Future with Shared Decision-making
Yasmine Probst, Prof, PhD, AdvAPD, FAIDH
- Dietary Factors in MS Onset and Progression
- (SYM02) The Benefits of Day Programs as Part of Comprehensive Care for People Living with MS
- Introduction to MS Day Programs
Brian Hutchinson, PT, MSCS - History and Evolution of MS Day Programs
Randall T. Schapiro, MD, FAAN - Connection to Combat Loneliness and Isolation
Tiffany Malone, MSW, MSCS - Incorporating Lifestyle Neurology into MS Management
Barbara Giesser, MD, FAAN, FANA, Dipl. ABLM - Outcomes of MS Day Programs
Brian Hutchinson, PT, MSCS
- Introduction to MS Day Programs
- SYM16 Novel Imaging Biomarkers in the New Diagnostic Criteria of MS
- New Diagnostic Criteria for MS
Daniel Ontaneda, MD, PhD - When and How to Image Patients with MS
Nancy Sicotte, MD - New Biomarkers: CVS and PRL
Daniel Ontaneda, MD, PhD - Imaging CVS and PRL
Pascal Sati, PhD - Clinical Cases for Discussion Panel
Nancy Sicotte, MD
- New Diagnostic Criteria for MS
- Fundamentals of MS Care Part 1
- The Natural History of MS (Epidemiology, Immunology, Pathophysiology)
Bruce Cohen, MD - Making the Diagnosis (Disease Mimics, Use of Paraclinical Tools)
Derrick Robertson, MD - MRI Mimics in the Diagnosis of MS
David Li, MD - Primary Progressive MS: Diagnosis, Clinical Course, and Management
Patricia Coyle, MD
- The Natural History of MS (Epidemiology, Immunology, Pathophysiology)
- Imaging, Cognitive, and Psychosocial Features of MS and Related Disorders
- Towards Precision Medicine in MS: Subjective Cognitive Fatigability Is Related to Psychosocial Fatigue, Cognitive Impairment, and Disability
Candice L. Craft, MS - Sulcal Morphometry Is Associated with Cognitive Performance and Cognitive Fatigue in Multiple Sclerosis
Cristina A.F. Román, PhD - Cognitive Concerns and Work: A Collaborative Occupational Therapy and Speech and Language Pathology Approach to Assessment and Treatment
Megan Parker, MScOT - Management of Psychological Comorbidities in Neuroimmunologic Disease
Virginia Baker, MD - The Importance of Super-Resolution and Harmonization in a Pragmatic Clinical MR Image Dataset
Savannah P. Hays, MSE - Remote Cognitive Monitoring in MS: A Path Toward Holistic Care with the Icometrix Platform
Enrique Alvarez, MD, PhD
- Towards Precision Medicine in MS: Subjective Cognitive Fatigability Is Related to Psychosocial Fatigue, Cognitive Impairment, and Disability
- John Kurtzke Memorial Lecture
Finding MS Therapies: Four Decades of Adventure and Misadventure
Robert J. Fox, MD, FAAN - (SYM21) Increasing Diversity in Clinical Research: Practical Applications
- Introduction: Multistakeholder Solutions
Mitzi Joi Williams, MD, FAAN, - The Investigator Role
Annette F. Okai, MD, FAAN - Role of Research Staff
Jacqueline Rosenthal, MD - Building Community Partnerships
Annette Howard, MD - Role of Academic Institutions/Learning Environments
Mima Akinsanya, MD
- Introduction: Multistakeholder Solutions
- (SYM24) Treatment Strategies in Relapsing MS
- Introduction
Scott D. Newsome, DO, MSCS, FAAN, FANA - Birds Eye View on Treatment Strategies
Scott D. Newsome, DO, MSCS, FAAN, FANA - Treatment Strategies in Multiple Sclerosis are Clear as a
Crystal Tirisham Gyang, MD - Treatment Strategies in Multiples Sclerosis are Clear as Mud
Ellen Mowry, MD, MCR, FAAN, FANA - Panel Roundtable-Case Presentations
- Introduction
- Fundamentals of MS Care Part 2
- Use and Effectiveness of Marijuana in MS: Research Update
Anthony Feinstein, MD, PhD, FRCPC - Women’s Issues in MS: Pregnancy, Sexual Function and Menopause
Riley Bove, MD - Day to Day Management: The Role of Triage Nurse
Charlotte Craig, MSN, RN, MSCN - Research in MS: Recruiting into Trials and the Role of the Research Nurse
Christina Isabell, RN
- Use and Effectiveness of Marijuana in MS: Research Update
- Disease Modifying Therapies Platforms
- No Rebound Observed Following Ozanimod Discontinuation in Female and Male Participants in the DAYBREAK Open-Label Extension Study
Bruce A.C. Cree, MD, PhD, MAS - Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and Potential Impact on B-Cell Levels: The Minore and Sopranino Trials
Riley Bove, MD - A Phase 1 Dose-Escalation Study of BMS-986353, a CD19 NEX-T, Evaluating Safety and Tolerability in Relapsing or Progressive Forms of Multiple Sclerosis (MS): Breakfree-2
Claire S. Riley, MD - Disability Outcomes in Tolebrutinib Phase 3 Trials in Non-Relapsing Secondary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis
Jiwon Oh, MD, PhD, FRCPC - Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the Fenopta Open-Label Extension
Amit Bar-Or, MD - Safety and Efficacy of Frexalimab from the Phase 2 Open-Label Extension in Participants with Relapsing Multiple Sclerosis: 2-Year Results
Stephen Krieger, MD
- No Rebound Observed Following Ozanimod Discontinuation in Female and Male Participants in the DAYBREAK Open-Label Extension Study
- Disease Management Platforms
- Impact of Relapses on Quality of Life and Economic Disease Burden in US Patients with Neuromyelitis Optica Spectrum Disorder
Benjamin J. Osborne, MD - The MS-Link™ Outcomes Study: Study Design and Descriptive Analyses of Patient-Reported Outcomes, Disease, and Sociodemographic Characteristics
Jeffrey English, MD - Reduce Your Risk of Falls©: A Group Coaching Program to Increase Mobility Confidence and Reduce Fall Risk in People with MS
Laura Allen, Associate Vice President of Operations - Disparities of Hypertension Awareness in Multiple Sclerosis: Age, Sex, and Severity
Michael V. Robers, MD, MS - Wearable Devices for Monitoring Incomplete Bladder Emptying in Multiple Sclerosis
Riley Bove, MD - No Association between Decreases in Serum Immunoglobulin Levels and Serious Infections with Long-Term Ublituximab Treatment in Patients with Relapsing Multiple Sclerosis
Bruce A.C. Cree, MD, PhD, MAS
- Impact of Relapses on Quality of Life and Economic Disease Burden in US Patients with Neuromyelitis Optica Spectrum Disorder
- Rehabilitation Platforms
- Is There a Threshold or Dose-Response Association between Physical Activity and Cognitive Function in Multiple Sclerosis?
Brenda Jeng, PhD - Long-Term Efficacy of Translingual Neurostimulation By a Portable Neuromodulation Stimulator on Gait Deficit Improvement in Multiple Sclerosis: Results from Ponstep Study
Deborah Backus, PhD, PT - Effectiveness of Facility-Based and Home-Based Exercise Programs for Multiple Sclerosis: The STEP for MS Trial
Deborah Backus, PhD, PT - Balancing Fatigue Mechanisms in Multiple Sclerosis through Low Load Blood Flow Restriction Resistance Exercise
Ethan C. Hill, PhD - Psychometric Properties of Free-Living Step-Based Metrics (Daily Steps and Peak Cadence) in Multiple Sclerosis
Peixuan Zheng, PhD - Walk It out: Acute Treadmill Walking Exercise Reduces State Anxiety in People with Multiple Sclerosis Who Have Generalized Anxiety Disorder
Petra Šili, BS
- Is There a Threshold or Dose-Response Association between Physical Activity and Cognitive Function in Multiple Sclerosis?
- Imaging, Cognitive, and Psychosocial Features of MS and Related Disorders
- Towards Precision Medicine in MS: Subjective Cognitive Fatigability Is Related to Psychosocial Fatigue, Cognitive Impairment, and Disability
Candice L. Craft, MS - Sulcal Morphometry Is Associated with Cognitive Performance and Cognitive Fatigue in Multiple Sclerosis
Cristina A.F. Román, PhD - Cognitive Concerns and Work: A Collaborative Occupational Therapy and Speech and Language Pathology Approach to Assessment and Treatment
Megan Parker, MScOT - Management of Psychological Comorbidities in Neuroimmunologic Disease
Virginia Baker, MD - The Importance of Super-Resolution and Harmonization in a Pragmatic Clinical MR Image Dataset
Savannah P. Hays, MSE - Remote Cognitive Monitoring in MS: A Path Toward Holistic Care with the Icometrix Platform
Enrique Alvarez, MD, PhD
- Towards Precision Medicine in MS: Subjective Cognitive Fatigability Is Related to Psychosocial Fatigue, Cognitive Impairment, and Disability
- Epidemiology and Social Determinants of Health
- Disease Severity and Disparities in Black and White People with Multiple Sclerosis: Sociodemographic and Modifiable Lifestyle Factors in a New York Population
Sarah Levy, PhD - Characterizing Disability and MRI Outcomes in Latinx People with Multiple Sclerosis before and after the COVID-19 Pandemic
Carrie M. Hersh, DO, MSc, FAAN - Optical Coherence Tomography Hyper-Reflective Foci in Pediatric Onset Multiple Sclerosis
Curtis M. Hay, MD, PhD - Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple Sclerosis
Fatemeh Siavoshi, MD - Race-Based Identity and Its Relationship with Neighborhood Marginalization and Mental Health in Pediatric-Onset Multiple Sclerosis
Paul Y. Yoo, PhD, OT - Clinical and Radiological Features in Mog-Negative Vs Mog-Positive Pediatric Acute Demyelinating Syndromes: One Entity or Multiple?
Areej Mahjoub, MD, FRCPC
- Disease Severity and Disparities in Black and White People with Multiple Sclerosis: Sociodemographic and Modifiable Lifestyle Factors in a New York Population
- John Kurtzke Memorial Lecture
- Fundamentals of MS Care Part 2
- Use and Effectiveness of Marijuana in MS: Research Update
Anthony Feinstein, MD, PhD, FRCPC - Women’s Issues in MS: Pregnancy, Sexual Function and Menopause
Riley Bove, MD - Day to Day Management: The Role of Triage Nurse
Charlotte Craig, MSN, RN, MSCN - Research in MS: Recruiting into Trials and the Role of the Research Nurse
Christina Isabell, RN
- Use and Effectiveness of Marijuana in MS: Research Update
- (SYM18) Women in MS Care and Their Allies: Building Skills for Thriving in Your Career
- Introductions
- Post-It Ice Breaker Session: Sharing Ideas and Knowledge Gaps
- Gratitude As a Way to Build Connections and Other Burnout Strategies
Amy Sullivan, PsyD, ABPP - Growing in Confidence and in Your Profession
Carrie M. Hersh, DO, MSc, FAAN - Building Your Agility for the Changing Times in Healthcare
Mary Rensel, MD, FAAN - Is the Grass Greener? …And Other Common Dilemmas
Mary Alissa Willis, MD, FAAN, FANA - Networking/Speed Mentoring/Sharing Ideas
- (SYM22) When Fulfillment Becomes an Internal Fight: Managing Burnout in Medicine
- Introductions and Worldview
Amy Sullivan, PsyD, ABPP - Impact of Stress on the Body
Amy Sullivan, PsyD, ABPP - Burnout Stories with Audience Process
Amy Sullivan, PsyD, ABPP; Carrie M. Hersh, DO, MSc, FAAN - Combating Burnout & Time Management for Work-Life Integration
Carrie M. Hersh, DO, MSc, FAAN
- Introductions and Worldview
- Current Topics and Trends in MS Rehab – Part 4 Patricia Bobryk, MHS, PT, MSCS, ATP, Moderator
- Session B: Navigating MS Rehabilitation: Fresh Perspectives and Challenges from Emerging Clinicians
Kasey Melsness, DPT; Andrea Tchir, MSc, OT; Megan Coyle, PT, DPT- Shared Experiences from Speakers in Clinical Work Since Onset of Career
- Current Challenges and Barriers to Success and Independence as a New Clinician
- Current Resources and Support Available to Us Currently Based on Location and Globally
- Closing the Gap. Shared Ideas on Mentorship, Managing Expectations, and Preventing Burnout
- Session B: Navigating MS Rehabilitation: Fresh Perspectives and Challenges from Emerging Clinicians